News Headlines

  1. Consulting And Services Firm ZS Opens Three New Offices: Seattle, Washington, DC And Cambridge, UK 1/2/2020

    In a move to continue expanding our firm’s global presence—and to increase our proximity to key clients—ZS is excited to announce that three new offices will open their doors on Jan. 2, 2020: Seattle, Washington, D.C., and Cambridge, U.K.

  2. Astellas Strengthens Immuno-Oncology Pipeline With Acquisition Of Xyphos Biosciences, Inc. 12/26/2019

    Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Xyphos Biosciences, Inc. (CEO: James Knighton, "Xyphos") today announced that Astellas has acquired Xyphos.

  3. TOWA PHARMACEUTICAL CO., LTD. Reaches An Agreement With ESTEVE To Acquire ESTEVE’s Generic Division, Pensa Investments 12/23/2019

    TOWA PHARMACEUTICAL CO.,LTD. (Osaka, Japan) (TOWA) and ESTEVE (Barcelona, Spain) announced today that TOWA will acquire 100% ownership of Pensa Investments, S.L. (Pensa), the generics division of the Spanish pharmaceutical company ESTEVE.

  4. Tessa Therapeutics To Open 90,000 Square Foot Commercial-Scale Cell Therapy Manufacturing Facility In Singapore In 2020 12/19/2019

    Tessa Therapeutics (Tessa), a clinical-stage cell therapy company focused on the development of innovative cell therapies to treat cancer, today announced plans to open a 90,000 square foot commercial-scale cell therapy manufacturing facility in Singapore by end-2020, which will be one of the leading commercial-scale cell therapy manufacturing facilities in Asia.

  5. CDMO Alcami Announces Plans To Add Capacity For Sterile Drug Product Development And Manufacturing 12/18/2019

    Alcami, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biologics industries, plans to expand the company’s current operations in North Charleston, South Carolina.

  6. Symbiosis Invests £1.5M In UK Facility Expansion 12/17/2019

    Fast-growing specialist sterile manufacturing and Contract Manufacturing Organisation (CMO) Symbiosis Pharmaceutical Services (Symbiosis), has expanded its sterile biologics manufacturing facility in Scotland, UK by 25%.

  7. Recipharm Partners With Aptahem For Formulation Of Apta-1 Drug Candidate 12/17/2019

    Recipharm, the contract development and manufacturing organisation (CDMO) has partnered with biotechnology company Aptahem, for the formulation of Apta-1 drug candidate.

  8. PCI Pharma Services Announces Major Manufacturing Facility Investment In Wales 12/11/2019

    PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, today announced it has begun an expansion of its Tredegar facility in Wales, UK to enhance its high potent drug manufacturing and development capabilities, including both clinical and commercial supply.

  9. Pelican BioThermal Achieves International ISO Accreditation 12/11/2019

    Pelican BioThermal, the global name in temperature-controlled packaging, announces it has achieved accreditation for technical competency within its laboratories in Europe and the US.

  10. Recipharm Invests In Its US Inhalation Development Service 12/9/2019

    Recipharm, the contract development and manufacturing organisation (CDMO), has invested USD 450,000 into its Research Triangle Park (RTP), North Carolina, US facility to install a SprayVIEW system that will support inhalation and nasal product development.